370 related articles for article (PubMed ID: 28562339)
1. FAM3A mediates PPARγ's protection in liver ischemia-reperfusion injury by activating Akt survival pathway and repressing inflammation and oxidative stress.
Chen Z; Wang J; Yang W; Chen J; Meng Y; Geng B; Cui Q; Yang J
Oncotarget; 2017 Jul; 8(30):49882-49896. PubMed ID: 28562339
[TBL] [Abstract][Full Text] [Related]
2. FAM3A Protects HT22 Cells Against Hydrogen Peroxide-Induced Oxidative Stress Through Activation of PI3K/Akt but not MEK/ERK Pathway.
Song Q; Gou WL; Zhang R
Cell Physiol Biochem; 2015; 37(4):1431-41. PubMed ID: 26492522
[TBL] [Abstract][Full Text] [Related]
3. FAM3A is a target gene of peroxisome proliferator-activated receptor gamma.
Zhou Y; Jia S; Wang C; Chen Z; Chi Y; Li J; Xu G; Guan Y; Yang J
Biochim Biophys Acta; 2013 Aug; 1830(8):4160-70. PubMed ID: 23562554
[TBL] [Abstract][Full Text] [Related]
4. FAM3A enhances adipogenesis of 3T3-L1 preadipocytes via activation of ATP-P2 receptor-Akt signaling pathway.
Chi Y; Li J; Li N; Chen Z; Ma L; Peng W; Pan X; Li M; Yu W; He X; Geng B; Cui Q; Liu Y; Yang J
Oncotarget; 2017 Jul; 8(28):45862-45873. PubMed ID: 28515350
[TBL] [Abstract][Full Text] [Related]
5. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
[TBL] [Abstract][Full Text] [Related]
6. Maresin 1 protects the liver against ischemia/reperfusion injury via the ALXR/Akt signaling pathway.
Tang D; Fu G; Li W; Sun P; Loughran PA; Deng M; Scott MJ; Billiar TR
Mol Med; 2021 Feb; 27(1):18. PubMed ID: 33632134
[TBL] [Abstract][Full Text] [Related]
7. Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver.
Yang W; Chen J; Meng Y; Chen Z; Yang J
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29701719
[TBL] [Abstract][Full Text] [Related]
8. TGR5 Attenuated Liver Ischemia-Reperfusion Injury by Activating the Keap1-Nrf2 Signaling Pathway in Mice.
Zhuang L; Ding W; Zhang Q; Ding W; Xu X; Yu X; Xi D
Inflammation; 2021 Jun; 44(3):859-872. PubMed ID: 33169298
[TBL] [Abstract][Full Text] [Related]
9. TSLP protects against liver I/R injury via activation of the PI3K/Akt pathway.
Li S; Yi Z; Deng M; Scott MJ; Yang C; Li W; Lei Z; Santerre NM; Loughran P; Billiar TR
JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723054
[TBL] [Abstract][Full Text] [Related]
10. CAAT/enhancer binding protein-homologous protein deficiency attenuates liver ischemia/reperfusion injury in mice.
Wada S; Hatano E; Yoh T; Nakamura N; Okuda Y; Okuno M; Kasai Y; Iwaisako K; Seo S; Taura K; Uemoto S
Liver Transpl; 2018 May; 24(5):645-654. PubMed ID: 29524333
[TBL] [Abstract][Full Text] [Related]
11. The Dichotomy of Endoplasmic Reticulum Stress Response in Liver Ischemia-Reperfusion Injury.
Zhou H; Zhu J; Yue S; Lu L; Busuttil RW; Kupiec-Weglinski JW; Wang X; Zhai Y
Transplantation; 2016 Feb; 100(2):365-72. PubMed ID: 26683513
[TBL] [Abstract][Full Text] [Related]
12. Myricitrin pretreatment ameliorates mouse liver ischemia reperfusion injury.
Shen Y; Shen X; Cheng Y; Liu Y
Int Immunopharmacol; 2020 Dec; 89(Pt A):107005. PubMed ID: 33045574
[TBL] [Abstract][Full Text] [Related]
13. Hesperidin ameliorates liver ischemia/reperfusion injury via activation of the Akt pathway.
Li S; Qin Q; Luo D; Pan W; Wei Y; Xu Y; Zhu J; Shang L
Mol Med Rep; 2020 Dec; 22(6):4519-4530. PubMed ID: 33174025
[TBL] [Abstract][Full Text] [Related]
14. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury.
Liu Y; Lu T; Zhang C; Xu J; Xue Z; Busuttil RW; Xu N; Xia Q; Kupiec-Weglinski JW; Ji H
J Hepatol; 2019 Oct; 71(4):719-730. PubMed ID: 31201834
[TBL] [Abstract][Full Text] [Related]
15. MTMR14 protects against hepatic ischemia-reperfusion injury through interacting with AKT signaling in vivo and in vitro.
Li S; Zhang M; Zhang B
Biomed Pharmacother; 2020 Sep; 129():110455. PubMed ID: 32768948
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K/Akt pathways.
Yu Y; Bai F; Liu Y; Yang Y; Yuan Q; Zou D; Qu S; Tian G; Song L; Zhang T; Li S; Liu Y; Wang W; Ren G; Li D
Mol Cell Biochem; 2015 May; 403(1-2):287-99. PubMed ID: 25701356
[TBL] [Abstract][Full Text] [Related]
17. FAM3A activates PI3K p110α/Akt signaling to ameliorate hepatic gluconeogenesis and lipogenesis.
Wang C; Chi Y; Li J; Miao Y; Li S; Su W; Jia S; Chen Z; Du S; Zhang X; Zhou Y; Wu W; Zhu M; Wang Z; Yang H; Xu G; Wang S; Yang J; Guan Y
Hepatology; 2014 May; 59(5):1779-90. PubMed ID: 24806753
[TBL] [Abstract][Full Text] [Related]
18. Suppression of microRNA‑27a protects against liver ischemia/reperfusion injury by targeting PPARγ and inhibiting endoplasmic reticulum stress.
Chi X; Jiang Y; Chen Y; Yang F; Cai Q; Pan F; Lv L; Zhang X
Mol Med Rep; 2019 Nov; 20(5):4003-4012. PubMed ID: 31485635
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin protection of livers from ischemia and reperfusion injury is dependent on both autophagy induction and mammalian target of rapamycin complex 2-Akt activation.
Zhu J; Lu T; Yue S; Shen X; Gao F; Busuttil RW; Kupiec-Weglinski JW; Xia Q; Zhai Y
Transplantation; 2015 Jan; 99(1):48-55. PubMed ID: 25340604
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice.
Kuboki S; Shin T; Huber N; Eismann T; Galloway E; Schuster R; Blanchard J; Zingarelli B; Lentsch AB
Hepatology; 2008 Jan; 47(1):215-24. PubMed ID: 18085707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
